Anti-phospholipid antibody mediated fetal loss: still an open question from a pathogenic point of view
- 30 March 2010
- journal article
- review article
- Published by SAGE Publications in Lupus
- Vol. 19 (4), 453-456
- https://doi.org/10.1177/0961203309361351
Abstract
Antiphospholipid antibodies (aPL) are associated with recurrent miscarriages and pregnancy complications, however their pathogenic mechanisms are still matter of research. Thrombotic events at the placental level cannot explain all of the clinical manifestations. It has been suggested that aPL may be responsible for a local acute inflammatory response mediated by complement activation and neutrophil infiltration eventually leading to fetal loss. However histological and immunohistological studies on human placental samples do support such a mechanism only in part and with no any clear relationship with the pregnancy outcome. A direct effect of aPL on both maternal and fetal placental tissues has been reported through the reactivity of the antibodies with beta2 glycoprotein I (β2GPI) expressed on the cell membranes. These events do not require an inflammatory response and can be in part related to the inhibition of growth factors favouring a physiological placentation. Understanding the different pathogenic mechanisms of aPL-associated miscarriages may help in improving our therapeutic approach particularly in recurrent cases not responsive to the usual treatment. Lupus (2010) 19, 453—456.This publication has 12 references indexed in Scilit:
- Antiphospholipid Antibodies and the Antiphospholipid Syndrome: Pathogenic MechanismsSeminars in Thrombosis and Hemostasis, 2008
- Updating on the Pathogenic Mechanisms 5 of the Antiphospholipid Antibodies-Associated Pregnancy LossClinical Reviews in Allergy & Immunology, 2008
- The Th1/Th2 paradigm: still important in pregnancy?Seminars in Immunopathology, 2007
- Excessive complement activation is associated with placental injury in patients with antiphospholipid antibodiesAmerican Journal of Obstetrics and Gynecology, 2007
- Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6Proceedings of the National Academy of Sciences of the United States of America, 2007
- Placental Pathology in Antiphospholipid SyndromePublished by Springer Science and Business Media LLC ,2006
- Impaired expression of endometrial differentiation markers and complement regulatory proteins in patients with recurrent pregnancy loss associated with antiphospholipid syndromeMolecular Human Reproduction, 2006
- Heparin prevents antiphospholipid antibody–induced fetal loss by inhibiting complement activationNature Medicine, 2004
- Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphos pholipid antibodies and recurrent spontaneous abortionAmerican Journal of Obstetrics and Gynecology, 1994
- Repeated fetal losses associated with antiphospholipid antibodies: A collaborative randomized trial comparing prednisone with low-dose heparin treatmentAmerican Journal of Obstetrics and Gynecology, 1992